BOSTON BEER CO INC (SAM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-27. Amounts in USD.

Revenue TTM

0 800M 1.6B 2.4B Q3 '21: 2.3B Q4 '21: 2.2B Q1 '22: 2.1B Q2 '22: 2.1B Q3 '22: 2.1B Q4 '22: 2.2B Q2 '23: 2.2B Q3 '23: 2.2B Q3 '23: 2.2B Q4 '23: 2.1B Q1 '24: 2.2B Q2 '24: 2.1B Q3 '24: 2.1B Q4 '24: 2.1B Q1 '25: 2.2B Q2 '25: 2.2B Q3 '25: 2.1B Q4 '25: 2.1B Q1 '26: 2.1B Q2 '26: 2B Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 350M 700M 1.1B Q3 '21: 914.3M Q4 '21: 797.8M Q1 '22: 721.1M Q2 '22: 711.2M Q3 '22: 796.2M Q4 '22: 862M Q2 '23: 844.7M Q3 '23: 853.1M Q3 '23: 870M Q4 '23: 852.4M Q1 '24: 883.1M Q2 '24: 875.4M Q3 '24: 880.9M Q4 '24: 893.7M Q1 '25: 926.6M Q2 '25: 952.7M Q3 '25: 945.6M Q4 '25: 952.6M Q1 '26: 947.3M Q2 '26: 941.1M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-150M 0 150M 300M 450M Q4 '19: 144.9M Q1 '20: 137M Q2 '20: 177.8M Q3 '20: 219.8M Q4 '20: 244.2M Q1 '21: 299.3M Q2 '21: 300.6M Q3 '21: 123.1M Q4 '21: 8M Q1 '22: -70.8M Q2 '22: -79.5M Q3 '22: 34.7M Q4 '22: 90.8M Q2 '23: 79M Q3 '23: 86M Q3 '23: 109.1M Q4 '23: 100M Q1 '24: 129.3M Q2 '24: 121.7M Q3 '24: 106.1M Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q4 '23 Q3 '24

Net Income TTM

-90M 0 90M 180M 270M Q4 '18: 92.7M Q1 '19: 107M Q2 '19: 111.4M Q3 '19: 118.1M Q4 '19: 110M Q1 '20: 104.6M Q2 '20: 136.9M Q3 '20: 172.9M Q4 '20: 192M Q1 '21: 239.3M Q4 '21: 14.6M Q1 '22: -53M Q4 '22: 67.3M Q2 '23: 60.3M Q3 '23: 64.9M Q3 '23: 83M Q4 '23: 76.2M Q1 '24: 97.8M Q2 '24: 92.1M Q3 '24: 80.3M Q1 '19 Q4 '19 Q3 '20 Q4 '21 Q2 '23 Q4 '23 Q3 '24

Cost of Revenue TTM

0 500M 1B 1.5B Q3 '21: 1.3B Q4 '21: 1.3B Q1 '22: 1.2B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.2B Q2 '23: 1.2B Q3 '23: 1.2B Q3 '23: 1.2B Q4 '23: 1.2B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1B Q4 '25: 1B Q1 '26: 997.8M Q2 '26: 984.3M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-100M 0 100M 200M 300M Q3 '21: 95.5M Q4 '21: 56.3M Q1 '22: -4.5M Q2 '22: 146.8M Q3 '22: 230.3M Q4 '22: 199.9M Q2 '23: 223.1M Q3 '23: 179.6M Q3 '23: 207.4M Q4 '23: 265.2M Q1 '24: 278.1M Q2 '24: 255.1M Q3 '24: 239.7M Q4 '24: 248.9M Q1 '25: 255.7M Q2 '25: 286.2M Q3 '25: 272.1M Q4 '25: 270.2M Q1 '26: 247.8M Q2 '26: 259.3M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-160M -80M 0 80M 160M 240M Q3 '21: -65.1M Q4 '21: -91.6M Q1 '22: -136.9M Q2 '22: 31.6M Q3 '22: 132.9M Q4 '22: 109.4M Q2 '23: 139M Q3 '23: 105M Q3 '23: 138.3M Q4 '23: 201.1M Q1 '24: 215.6M Q2 '24: 189.8M Q3 '24: 171.7M Q4 '24: 172.6M Q1 '25: 185.3M Q2 '25: 221.9M Q3 '25: 211.9M Q4 '25: 215.6M Q1 '26: 190.8M Q2 '26: 206M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '20: 12.2M Q2 '20: 12.3M Q3 '20: 12.3M Q1 '21: 12.5M Q2 '21: 12.5M Q3 '21: 12.3M Q1 '22: 12.3M Q2 '22: 12.3M Q3 '22: 12.3M Q2 '23: 12.3M Q3 '23: 12.3M Q3 '23: 12.2M Q1 '24: 12.1M Q2 '24: 11.9M Q3 '24: 11.7M Q1 '25: 11.3M Q2 '25: 11.1M Q3 '25: 10.8M Q1 '26: 10.5M Q2 '26: 10.4M Q2 '20 Q2 '21 Q2 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.00 0.00 7.00 14.00 21.00 Q4 '19: 9.15 Q1 '20: 8.62 Q2 '20: 11.14 Q3 '20: 14.00 Q4 '20: 15.52 Q1 '21: 19.29 Q2 '21: 19.16 Q3 '21: 7.89 Q4 '21: 1.17 Q1 '22: -4.25 Q2 '22: -4.69 Q3 '22: 2.28 Q4 '22: 5.44 Q2 '23: 4.87 Q3 '23: 5.28 Q3 '23: 6.77 Q4 '23: 6.21 Q1 '24: 7.98 Q2 '24: 7.65 Q3 '24: 6.81 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q4 '23 Q3 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.